Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

OBJECTIVE: To determine the respective associations of premorbid glucagon-like peptide-1 receptor agonist (GLP1-RA) and sodium–glucose cotransporter 2 inhibitor (SGLT2i) use, compared with premorbid dipeptidyl peptidase 4 inhibitor (DPP4i) use, with severity of outcomes in the setting of severe acut...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahkoska, Anna R., Abrahamsen, Trine Julie, Alexander, G. Caleb, Bennett, Tellen D., Chute, Christopher G., Haendel, Melissa A., Klein, Klara R., Mehta, Hemalkumar, Miller, Joshua D., Moffitt, Richard A., Stürmer, Til, Kvist, Kajsa, Buse, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323175/
https://www.ncbi.nlm.nih.gov/pubmed/34135013
http://dx.doi.org/10.2337/dc21-0065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323175/
https://www.ncbi.nlm.nih.gov/pubmed/34135013
http://dx.doi.org/10.2337/dc21-0065

Ejemplares similares